+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Johnson & Johnson Services, Inc. - logo

Johnson & Johnson has more than 250 companies located in 60 countries around the world. Their companies are broken down into several business segments: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson’s consumer healthcare segment produces a variety of consumer care products in the areas of baby care, skin and hair care, wound care, oral health, OTC medicines and nutritionals. Their medical devices segment produces a broad range of products used by healthcare professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, cardiovascular disease, sports medicine, and aesthetics. The Janssen Pharmaceutical Companies of Johnson & Johnson are focused on oncology, immunology, neuroscience and infectious diseases, as well as cardiovascular and metabolic diseases. Their company headquarters are based in New Brunswick, New Jersey, USA.

From
Baby Wipes Market 2024-2028 - Product Thumbnail Image

Baby Wipes Market 2024-2028

  • Report
  • May 2024
  • 174 Pages
  • Global
From
Over The Counter Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Over The Counter Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
From
From
Acute Ischemic Stroke Diagnosis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Acute Ischemic Stroke Diagnosis Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
From
Detachable Embolization Coil Market - Global Forecast 2026-2032 - Product Thumbnail Image

Detachable Embolization Coil Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 197 Pages
  • Global
From
Expandable Embolization Coils Market - Global Forecast 2026-2032 - Product Thumbnail Image

Expandable Embolization Coils Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 197 Pages
  • Global
From
Anti-Inflammatory Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 488 Pages
  • Global
From
Pharmerging - Global Strategic Business Report 2026 - Product Thumbnail Image

Pharmerging - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 198 Pages
  • Global
From
Prescription Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Prescription Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 362 Pages
  • Global
From
From
From
From
TNF Inhibitors - Global Strategic Business Report - Product Thumbnail Image

TNF Inhibitors - Global Strategic Business Report

  • Report
  • November 2026
  • 191 Pages
  • Global
From
Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 287 Pages
  • Global
From
Loading Indicator